Tag Archives: oligometastatic
Dr. Greg Riely (Pt 2): Should local ablation therapy in oligometastatic or oligoprogressing cancer be incorporated into routine practice?
Local Therapy for Advanced NSCLC: Revising Outdated Principles for Selected Patients (BMIC-062)
Dr. Jack West reviews general principles for how local therapies are increasingly appropriate for selected patients with advanced NSCLC, whether at initial management, for limited progression on systemic therapy, or as local consolidation therapy. (15:36)
Does Adjuvant Sunitinib Offer a Benefit after Oligometastasectomy for Kidney Cancer? Highlights from ASCO 2018 (BMIC-052)
Dr. Daniel Goldstein summarizes the findings of a randomized trial assessing the benefit of adjuvant sunitinib following resection of oligometastatic disease in patients with renal cell carcinoma (RCC). (2:06)